早期和晚期的抗体中介排斥:补充体在玩什么游戏?
Marco Delsante1, Ilaria Gandolfini1, Alessandra Palmisano1
1Nephrology Unit, Parma University Hospital, & Department of Medicine and Surgery, University of Parma, Parma, Italy.
Transplantation reviews (Orlando, Fla.)
|November 26, 2024
概括
补充激活是早期抗体介导排斥 (AMR) 的关键,但晚期的AMR可能涉及补充独立的途径. 了解这些差异对于为脏移植接受者量身定制治疗至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- 补体系统在移植后的抗体中介排斥 (AMR) 中起作用.
- 活检中的补体碎片证实了AMR,但抗体驱动的损伤可以在没有补体激活的情况下发生.
- 在晚期AMR (>移植后6个月) 中,补充独立的机制可能更显著.
研究的目的:
- 审查关于补充激活在早期和晚期AMR中的不同作用的证据.
- 探索不同的捐赠者特异性抗体 (DSA) 和补充抑制剂如何影响AMR.
- 为了突出晚期AMR和C4d阴性AMR特征的融合.
主要方法:
- 文献综述分析了AMR的诊断迹象.
- 随着时间的推移,对C4d染色发病率的检查移植后.
- 对抗补充疗法的差异反应的分析.
- 评估补充系统激活的直接和间接指标.
主要成果:
- 有证据表明,相比于早期AMR,晚期AMR的补体激活率较低.
- 移植后补体抑制剂的下调可能有利于早期的补体激活.
- 晚期AMR和C4d阴性AMR的临床和组织学特征显示了相似之处.
结论:
- 对抗药物耐药性的治疗策略应考虑潜在的病理生理机制的时间依赖差异.
- 区分早期和晚期AMR对于优化治疗至关重要.
- 补充激活模式在早期和晚期抗体中介排斥之间存在显著差异.
相关概念视频
Cell-mediated Immune Responses
67.1K
Overview
67.1K
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Complement System
2.3K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.3K
Allergic Drug Reactions
812
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
812
Humoral Immune Responses
71.6K
Overview
71.6K
Antigen Processing Pathways
940
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
940


